Vertical: Life Sciences

The Six Five team discusses IBM's announcement that Watsonx.ai and .data are "going GA."
IBM posted a solid second quarter for fiscal year 2023, with revenue of $15.48 billion, which just missed analyst estimates, and earnings per share of $2.18 that handily beat analyst estimates of $2.01 per share
Daniel Newman and Todd R. Weiss of The Futurum Group share their insights as IBM’s Q2 earnings beat EPS estimates, just missing on analyst revenue estimates, as the company launches its new watsonx generative AI and data platform into general availability. The nascent watsonx platform is positioned to help drive broad enterprise success in generative AI for the company.
A Look at Workhuman’s Platform Including Workhuman iQ and Inclusion Advisor
Sherril Hanson, Senior Analyst at The Futurum Group, shares insights from a recent demo of Workhuman’s rewards and recognition platform, particularly its unique features such as the Inclusion Advisor and the upcoming Workhuman iQ App.
Futurum analyst Todd R. Weiss shares his insights as a healthcare quantum computer debuts for Cleveland Clinic, IBM, as they partner to launch the first onsite private sector IBM-managed quantum computer in the U.S. that aims to help accelerate treatment discoveries across a wide range of biomedical fields.
In this episode of the Futurum Tech Webcast, Futurum principal analyst Shelly Kramer is joined by Manu Vohra, Managing Director, Global Life Sciences for Box, for a conversation on collaboration in the life sciences industry and exploring how Box’s Content Cloud for Life Sciences is playing a big role in helping organizations speed their digital transformation journeys.
In this latest research brief, The Content Cloud for Life Sciences Securely Streamlines Seamless Collaboration — done in partnership with Box — Futurum analyst Shelly Kramer explores the current state of collaboration in the life sciences industry and analyzes the growing need for a secure, frictionless collaboration platform.
Futurum's principal analyst Daniel Newman dives into Micron's announced plans this week to invest $40 billion to manufacture chips in the U.S. by the end of the decade.
On this special episode of the Futurum Tech Webcast – Interview Series I am joined Aparna Seksaria, Global Practice Lead R&D Solutions, Life Sciences. In our conversation we discuss the areas of opportunities for the life sciences industry, a look into how life sciences organizations have tackled the value chain challenges brought about by the pandemic, and more. It's a conversation you won't want to miss.
How are companies using edge computing and IoT to support their digital transformation efforts? The following are just a few real-world examples.
In a move to deepen its capabilities to serve the life sciences sector, Honeywell announced the $1.3 billion acquisition of Sparta Systems.

Thank you, we received your request, a member of our team will be in contact with you.